Home » Topics » BioWorld Science

BioWorld Science
RSS

IgG4:IgG RNA ratio as a marker of disease activity in granulomatosis with polyangiitis

Feb. 5, 2019

Evidence of molecular mechanism of DZ-2002 on glomerulonephritis in SLE

Feb. 5, 2019

VU-6001376 demonstrates efficacy in preclinical model of Parkinson's disease

Feb. 5, 2019

TNF levels do not predict TNF blocker success

Feb. 5, 2019

Separating latent from dead HIV genomes

Feb. 5, 2019

NanoViricides advances shingles drug candidate NV-HHV-101 into IND-enabling studies

Feb. 5, 2019

EBV and cancer linked in more ways than one

Feb. 5, 2019

Phase II trial investigates TIMP-GLIA in subjects with celiac disease

Feb. 5, 2019

Aprea initiates phase III study of APR-246 and azacitidine for TP53 mutant MDS

Feb. 5, 2019

I-Mab and BCT to collaborate on arginine depletion therapy

Feb. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...